Apunts is focused, on the one hand, on the impact of high sports performance on men and women and, especially, in the study of team sports and muscle and tendon injuries. On the other hand, on the behaviour to follow while practicing sport or physical activity during illnesses or in certain situations. All of which undergo an anonymous external peer review process. CiteScore measures average citations received per document published.
|Published (Last):||20 November 2014|
|PDF File Size:||8.22 Mb|
|ePub File Size:||20.2 Mb|
|Price:||Free* [*Free Regsitration Required]|
Print Download. Examples: Cancer AND drug name. Pneumonia AND sponsor name. How to search [pdf]. For these items you should use the filters and not add them to your search terms in the text field. Print Download Summary. Review by the Competent Authority or Ethics Committee in the country concerned. As of 1. EU Clinical Trials Register.
Search tools. Select Date Range: to. Select Rare Disease:. IMP with orphan designation in the indication. Orphan Designation Number:. Results Status: Trials with results Trials without results. Clear advanced search filters. Date on which this record was first entered in the EudraCT database:. View results. Title of the trial for lay people, in easily understood, i. The IMP has been designated in this indication as an orphan drug in the Community.
Committee on Advanced therapies CAT has issued a classification for this product. Combination product that includes a device, but does not involve an Advanced Therapy. Severity CGI-S. Written informed consent from parent s or legal guardian s with sufficient intellectual capacity to understand the study and support subjects?
In accordance with Institutional Review Board IRB or Independent Ethics Committee IEC requirements, the subject will complete an informed assent when developmentally appropriate, to participate in the study before conduct of any study-specific procedures.
Subject is judged by the investigator to be appropriate for participation in a week clinical trial in an outpatient setting involving open-label lurasidone treatment, and is able to comply with the protocol. A reliable informant eg, parent, legal guardian, or caregiver must be available to accompany the subject at each visit.
Females who participate in this study: - are unable to become pregnant eg, premenarchal, surgically sterile, etc. OR - practices true abstinence consistent with lifestyle and must agree to remain abstinent from signing informed consent to at least 30 days after the last dose of study drug has been taken; OR - are sexually active and willing to use a medically effective method of birth control eg, male using condom and female using condom, diaphragm, contraceptive sponge, spermicide, contraceptive pill, or intrauterine device from signing informed consent to at least 30 days after the last dose of study drug has been taken.
Males must be willing to remain sexually abstinent consistent with lifestyle or use an effective method of birth control eg, male using condom and female using condom, diaphragm, contraceptive sponge, spermicide, contraceptive pill, or intrauterine device from signing informed consent to at least 30 days after the last dose of study drug has been taken.
El sujeto ha completado el estudio D visita 9 ; O el sujeto ha completado el estudio D visita 9. Un informador fiable p. Las mujeres que participen en este estudio:?
Subject is considered by the investigator to be at imminent risk of suicide or injury to self, others, or property. Exhibits evidence of moderate or severe extrapyramidal symptoms, dystonia, tardive dyskinesia, or any other moderate or severe movement disorder.
Severity to be determined by the investigator. La intensidad la debe determinar el investigador. Safety Assessments All Subjects:?
Laboratory tests, vital signs, body weight and body mass index BMI , physical examination, height as measured by stadiometer , electrocardiogram ECG ;? Tanner staging, and menstrual cyclicity female subjects.
For subjects continued from Study D? Effectiveness Assessments All Subjects:? Clinician-rated Children? Evaluaciones de la seguridad Todos los sujetos:? Estadios de Tanner y ciclicidad menstrual mujeres. Evaluaciones de la eficacia Todos los sujetos:? Cuestionario de carga del cuidador CGSQ. Evaluaciones de la seguridad: Todos los sujetos:? Evaluaciones de la eficacia: Todos los sujetos:? The trial involves single site in the Member State concerned.
Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial. Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition. Please ref to: Section
Estadio de Lasesarre (Nuevo Lasesarre)
These images are a random sampling from a Bing search on the term "Female Tanner Stage. Search Bing for all related images. Started in , this collection now contains interlinked topic pages divided into a tree of 31 specialty books and chapters. Content is updated monthly with systematic literature reviews and conferences. Although access to this website is not restricted, the information found here is intended for use by medical providers. Patients should address specific medical concerns with their physicians. Toggle navigation.